Longitudinal trends in mammographic percent density and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 5, 2007, Pages 921-928

  Vachon, Celine M ^a   Pankratz, V Shane ^a   Scott, Christopher G ^a   Maloney, Shaun D ^a   Ghosh, Karthik ^a   Brandt, Kathleen R ^a   Milanese, Tia ^a   Carston, Michael J ^a   Sellers, Thomas A ^b  

^a Mayo Clinic   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILATERAL CANCER; BREAST CANCER; BREAST ENDOPROSTHESIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MENOPAUSE; PARITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MINNESOTA; ODDS RATIO; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK FACTORS; TIME FACTORS;

EID: 34250366942     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-1047     Document Type: Article

References (43)

1. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
2. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
3. Wolfe JN, Albert S, Belle S, Salane M. Familial influences on breast parenchymal patterns. Cancer 1980;46:2433-7.
4. Kaprio J, Alanko A, Kivisaari L, Standertskjold-Nordenstam CG. Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol 1987;60:459-62.
5. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
6. Pankow JS, Vachon CM, Kuni CC, et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 1997;89:549-56.
7. Warren R. Hormones and mammographic breast density. Maturitas 2004;49:67-78.
8. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004;96:621-8.
9. Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW. Can mammographic densities predict effects of tamoxifen on the breast? J Natl Cancer Inst 1996;88:128-9.
10. Atkinson C, Warren R, Bingham SA, Day NE. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999;8:863-6.
11. Boyd NF, Martin L, Stone J, et al. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53.
12. Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006;15:732-9.
13. Salminen TM, Saarenmaa IE, Heikkila MM, Hakama M. Risk of breast cancer and changes in mammographic parenchymal patterns over time. Acta Oncol 1998;37:547-51.
14. van Gils CH, Hendriks JH, Holland R, et al. Changes in mammographic density and concomitant changes in breast cancer risk. Eur J Cancer Prev 1999;8:509-15.
15. Saftlas AF, Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 1987;9:146-74.
16. Byng JW, Boyd NF, Little L, et al. Symmetry of projection in the quantitative analysis of mammogram images. Eur J Cancer Prev 1996;5:319-27.
17. Vachon CM, Brandt KR, Ghosh K, et al. Mammographic density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:43-9.
18. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994;39:1629-38.
19. Boyd NF, Lockwood GA, Martin LJ, et al. Mammographic densities and risk of breast cancer among subjects with a family history of this disease. J Natl Cancer Inst 1999;91:1404-8.
20. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
21. Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003;12:332-8.
22. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health 1993;14:43-68.
23. Torres-Mejia G, De Stavola B, Allen DS, et al. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 2005;14:1052-9.
24. Boyd NF, Martin LJ, Li Q, et al. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:961-6.
25. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
26. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53.
27. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000;11:653-62.
28. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65.
29. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
30. Greendale GA, Palla SL, Ursin G, et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 2005;162:826-34.
31. Boyd NF, Stone J, Martin LJ, et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002;87:876-82.
32. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:2641-7.
33. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. Proceedings of the Fifth Annual AACR International Conference, Frontiers in Cancer Prevention Research; 2006. p. 126.
34. Geschickter CF. Diseases of the Breast. 2nd ed. Philadelphia, PA: J.B. Lippincott Co.; 1945.
35. Cowan DF, Herbert TA. Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. J Surg Pathol 1989;2:323-33.
36. Hutson SW, Cowen PN, Bird CC. Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 1985;38:281-7.
37. Vorrherr H. The Breast: Morphology, Physiology, and Lactation. New York: Academic Press; 1974.
38. Milanese TR, Hartmann LC, Sellers TA, et al. Age-related lobular involution and reduced risk of breast cancer. J Natl Cancer Inst 2006;98:1600-7.
39. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7.
40. Vachon CM, Sellers TA, Vierkant RA, Wu FF, Brandt KR. Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev 2002;11:1382-8.
41. McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst 2005;97:1366-76.
42. Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 1997;89:488-96.
43. Chlebowski RT, McTiernan A. Biological significance of interventions that change breast density. J Natl Cancer Inst 2003;95:4-5.